Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus
- 23 March 2009
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 169 (6), 616-625
- https://doi.org/10.1001/archinternmed.2009.20
Abstract
Research from JAMA Internal Medicine — Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes MellitusKeywords
This publication has 26 references indexed in Scilit:
- The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in DiabetesDiabetes Care, 2006
- Retinal vascular manifestations of metabolic disordersTrends in Endocrinology & Metabolism, 2006
- Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metforminDiabetologia, 2006
- Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetesDiabetic Medicine, 2005
- The diabetes epidemic: a national and global crisisAmerican Journal Of Medicine, 2004
- Combination of Insulin and Metformin in the Treatment of Type 2 DiabetesDiabetes Care, 2002
- Before oral agents fail: the case for starting insulin earlyInternational Journal of Obesity, 2002
- Metformin reduces systemic methylglyoxal levels in type 2 diabetes.Diabetes, 1999
- Clinical Examination Versus Neurophysiological Examination in the Diagnosis of Diabetic PolyneuropathyDiabetic Medicine, 1992
- Repeated measures in clinical trials: Analysis using mean summary statistics and its implications for designStatistics in Medicine, 1992